Does PSA Velocity Predict Prostate Cancer in Pre-Screened Populations?
- 31 March 2006
- journal article
- Published by Elsevier in European Urology
- Vol. 49 (3), 460-465
- https://doi.org/10.1016/j.eururo.2005.12.026
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The PSA Era is not Over for Prostate CancerEuropean Urology, 2005
- EAU Guidelines on Prostate CancerEuropean Urology, 2005
- The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USABJU International, 2004
- THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?Journal of Urology, 2004
- Prostate-specific antigen change in the european randomized study of screening for prostate cancer, section rotterdamUrology, 2004
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/mlUrology, 2002
- A MODEL FOR THE NUMBER OF CORES PER PROSTATE BIOPSY BASED ON PATIENT AGE AND PROSTATE GLAND VOLUMEJournal of Urology, 1998
- Rate of Change in Serum Prostate Specific Antigen Levels as a Method For Prostate Cancer DetectionJournal of Urology, 1994
- Latent Prostatic Cancer in a Consecutive Autopsy SeriesScandinavian Journal of Urology and Nephrology, 1980